Germany· DE-A57-32ce17b2deb8414a
Zonisamid Glenmark
A zonisamide product containing zonisamide, registered in Germany by Glenmark Arzneimittel Gmbh. The same ATC class is registered in 18 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Zonisamide is registered in 18 of 19 countries.
Countries holding a registration under ATC N03AX15 (zonisamide), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 11 of them publish a price we can compare per daily dose
Zonisamide · ATC N03AX15
18 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of zonisamide costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), the median price runs from $0.78 in United States to $10.28 in Switzerland — a ×13 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Zonisamide · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$10.28
- IT Italy$2.90
- FR France$1.20
- US United States$0.78 (acquisition cost)
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Zonisamide
- Manufacturer
- Glenmark Arzneimittel Gmbh
- Country
- Germany (DE)
- ATC code
- N03AX15
- ATC class
- Zonisamide
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
239 interactions on record for zonisamide.
Graded by severity as the source publishes them — 43 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Zonisamide · interactions on record
239 records
- 43 severe
- 105 moderate
- 66 info
Most severe, free to view
- DicycloverineA03AA07severe
- PropanthelineA03AB05severe
- MepenzolateA03AB12severe
- TrospiumA03AB20severe
25 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Zonisamide in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDesizon 20mg/ml oral suspensionDesitin Pharma Ltd
- CzechiaERSITTINEgis Pharmaceuticals PLC, Budapešť
- SpainNYZOL 100 MG CAPSULAS DURAS EFGNeuraxpharm Spain S.L.
- United StatesZonegranAdvanz Pharma (US) Corp.
- FinlandZonegranParanova Oy
- FranceZONEGRAN 100 mg, géluleAMDIPHARM
- NetherlandsZonegran 100 mg, capsules hardAmdipharm Limited
- SwedenZonegran 100 mg Kapsel, hårdAmdipharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Zonisamid Aristo
- Bulgaria · Зокап
- Czechia · Ersittin, Zonisamid Sandoz
- Denmark · Zonisamid Desitin, Zonisamid Glenmark
- Estonia · Zonisamide Sandoz
- Spain · Nyzol, Zonesme
- Finland · Zonisamide Desitin
- France · Zonisamide Arrow, Zonisamide Neuraxpharm
- United Kingdom (Northern Ireland) · Desizon, Zonisamide Accord
- Croatia · Zocap
- Ireland · Zonisamide Desitin, Zonisamide Rowex
- Iceland · Zonegran, Zonisamide Viatris
- Italy · Zonisamide Doc Generici, Zonisamide Sandoz
- Liechtenstein · Zonegran, Zonisamide Viatris
- Lithuania · Zonisamide Sandoz
- Malta · Zonisamide Doc Generici
- Netherlands · Zonisamide Indoco, Zonisamide Sandoz
- Norway · Zonegran, Zonisamid Desitin
- Poland · Zonisamidum Neuraxpharm
- Portugal · Zonisamida Aristo, Zonisamida Generis
- Romania · Zocap, Zonisamidă Desitin
- Sweden · Zonisamide 1a Farma
- Slovenia · Zocap, Zonisamid Sandoz
- Slovakia · Zonisamide Neuraxpharm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bf7619ea-03c7-497e-b428-67bd901c92a4 GET /v1/drugs/bf7619ea-03c7-497e-b428-67bd901c92a4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Zonisamide",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about zonisamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.